BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2831007)

  • 21. Endogenous digoxin-immunoreactive substance in normal and preeclamptic pregnancies.
    Loğoğlu G; Erdoğan S; Ozgünen FT; Doğan A; Ozgünen T; Kadayifçi O
    Int J Gynaecol Obstet; 1993 Nov; 43(2):137-43. PubMed ID: 7905428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digoxin-like immunoreactive substance in pregnancy.
    González AR; Phelps SJ; Cochran EB; Sibai BM
    Am J Obstet Gynecol; 1987 Sep; 157(3):660-4. PubMed ID: 2820228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digoxin-like immunoreactive factor in twin and pregnancy-associated hypertensive pregnancies.
    Jakobi P; Krivoy N; Weissman A; Paldi E
    Obstet Gynecol; 1989 Jul; 74(1):29-33. PubMed ID: 2733937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ouabain-like factor: is this the natriuretic hormone?
    Ferrandi M; Manunta P
    Curr Opin Nephrol Hypertens; 2000 Mar; 9(2):165-71. PubMed ID: 10757222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of urinary 11-keto-thromboxane B2 in normal and hypertensive pregnancies.
    Tannirandorn Y; Sullivan MH; Elder MG
    Prostaglandins Leukot Essent Fatty Acids; 1991 Feb; 42(2):91-4. PubMed ID: 2020732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pregnancy-induced hypertension and pre-eclampsia develop in spite of high circulating levels of cardionatrin].
    Fiévet P; Fournier A; De Bold A; el-Esper N; Grégoire I; Renaud H; Westeel PF; Makdassi R
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):936-41. PubMed ID: 2959237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digoxin-like immunoreactive factor, corticotropin-releasing factor, and pregnancy.
    Wolfe C; Poston L; Jones M
    Lancet; 1987 Feb; 1(8528):335-6. PubMed ID: 2880155
    [No Abstract]   [Full Text] [Related]  

  • 28. Urinary kallikrein excretion in normal and hypertensive pregnancy at term.
    Sipilä R; Jalkanen M; Huotari K
    Ann Clin Res; 1986; 18(4):208-10. PubMed ID: 3641602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous natriuretic and ouabain-like factors. Their roles in body fluid volume and blood pressure regulation.
    Kramer HJ; Meyer-Lehnert H; Michel H; Predel HG
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):81-9. PubMed ID: 1848764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
    Haddy FJ; Pamnani MB
    Clin Exp Hypertens; 1998; 20(5-6):499-508. PubMed ID: 9682906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma renin activity, blood uric acid and plasma volume in pregnancy-induced hypertension.
    Fievet P; Pleskov L; Desailly I; Carayon A; de Fremont JF; Coevoet B; Comoy E; Demory JE; Verhoest P; Boulanger JC
    Nephron; 1985; 40(4):429-32. PubMed ID: 3895007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium excretion in normal and hypertensive pregnancy: a prospective study.
    Brown MA; Gallery ED; Ross MR; Esber RP
    Am J Obstet Gynecol; 1988 Aug; 159(2):297-307. PubMed ID: 3044110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin-like immunoreactivity, endogenous cardiac glycoside-like factor(s) and natriuretic hormone: more than a hypothesis.
    Clerico A
    J Nucl Med Allied Sci; 1987; 31(4):341-56. PubMed ID: 2832557
    [No Abstract]   [Full Text] [Related]  

  • 34. Markers of sodium and volume homeostasis in pregnancy-induced hypertension.
    Seely EW; Williams GH; Graves SW
    J Clin Endocrinol Metab; 1992 Jan; 74(1):150-6. PubMed ID: 1727815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The possible role of digitalislike factors in pregnancy-induced hypertension.
    Graves SW
    Hypertension; 1987 Nov; 10(5 Pt 2):I84-6. PubMed ID: 3679448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sodium intake on the excretion of urinary natriuretic factor in essential hypertensives.
    Morise T; Miyamori I; Hifumi S; Okamoto S; Ikeda M; Takeda Y; Koshida H; Yasuhara S; Takeda R
    Endocrinol Jpn; 1985 Jun; 32(3):405-11. PubMed ID: 2995016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive mechanism of exercise.
    Arakawa K
    J Hypertens; 1993 Mar; 11(3):223-9. PubMed ID: 8387079
    [No Abstract]   [Full Text] [Related]  

  • 38. Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy.
    Weinberger MH; Kramer NJ; Petersen LP; Cleary RE; Young PC
    Perspect Nephrol Hypertens; 1976; 5():263-9. PubMed ID: 1005040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 11 beta-Hydroxysteroid dehydrogenase and its inhibitors in hypertensive pregnancy.
    Walker BR; Williamson PM; Brown MA; Honour JW; Edwards CR; Whitworth JA
    Hypertension; 1995 Apr; 25(4 Pt 1):626-30. PubMed ID: 7721407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous digitalis-like factors.
    Graves SW
    Crit Rev Clin Lab Sci; 1986; 23(3):177-200. PubMed ID: 3015491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.